A 40something woman was thought to be too young for glaucoma but more people below age 60 are being diagnosed with glaucoma ...

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...

Medical experts in Plateau State have raised serious concerns over the rate at which glaucoma is spreading in the state, with ...

Glaucoma develops when fluid inside the eye doesn’t drain properly, causing pressure to build up over time and damage the ...

Health experts in Plateau and Kaduna States have raised an alarm over the growing burden of glaucoma, urging Nigerians to undergo ...

Qlaris Bio appointed Fred Guerard, PharmD, as its president and CEO, according to a press release. The company is entering phase 3 development of QLS-111, a novel eye drop for lowering IOP in patients ...

Many people are unaware that they have this common eye condition.

At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and treatment burden in patients ...

SpyGlass Pharma Inc., which is promising an intraocular lens that will reshape the treatment of glaucoma, emerged from its initial public offering last month with a big boost from Wall Street.

The US Food and Drug Administration (FDA) has granted permission to conduct the first clinical trials of cell rejuvenation therapy in humans. This was reported by the journal Nature Biotechnology.

Open-angle glaucoma is a risk factor for vascular and frontotemporal dementia in patients with type 2 diabetes, according to a study.